Đánh giá mức độ rối loạn thần kinh tự chủ trên bệnh Parkinson và teo đa hệ thống

65. Ian R.A.M (2001), "The pathology of Parkinson’s disease", BCMJ, 43 (3), pp. 142 - 47.

66. Iodice V., Low D. A., Vichayanrat E., Mathias C. J. (2011), "Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences", J Neurol Sci, 310 (1-2), pp. 133- 8.

67. Irwin D. J., Lee V. M. Y., Trojanowski J. Q. (2013), "Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies", Nature Reviews Neuroscience, 14, pp. 626.

68. Ivanov B., Valkanova V., Deleva N. (2004), "Cardiovascular autonomic disturbances in early Parkinsons disease", J of IMAB, 10 (1), pp. 15 - 18

69. Jamora R. D., Gupta A., Tan A. K., Tan L. C. (2005), "Clinical characteristics of patients with multiple system atrophy in Singapore", Ann Acad Med Singapore, 34 (9), pp. 553-7.

70. Jellinger K. A. (2014), "Neuropathology of multiple system atrophy: new thoughts about pathogenesis", Mov Disord, 29 (14), pp. 1720-41.

71. Kim J. B., Kim B. J., Koh S. B., Park K. W. (2014), "Autonomic dysfunction according to disease progression in Parkinson's disease", Parkinsonism Relat Disord, 20 (3), pp. 303-7.

72. Kim W. C., Lee H. J., Yang J. W (1998), "Autonomic dysfunction in de novo patients with idiopathic Parkinson’s disease and multiple system atrophy", J Korean Neurol Assoc, 16 (6), pp. 851-858.

73. Kimpinski K., Iodice V., Burton D. D., Camilleri M., Mullan B. P., et al. (2012), "The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy", J Neurol Sci, 317 (1-2), pp. 92-6.

Có thể bạn quan tâm!

Xem toàn bộ 217 trang tài liệu này.

74. Kirkwood B. R., Sterne J. A. C. (2003), "Essential Medical Statistics",

Blackwell Publishing, pp. 420.

75. Korchounov A., Kessler K. R., Yakhno N. N., Damulin I. V., Schipper

H. I. (2005), "Determinants of autonomic dysfunction in idiopathic Parkinson's disease", J Neurol, 252 (12), pp. 1530-6.

76. Kucera P., Goldenberg Z., Kurca E. (2004), "Sympathetic skin response: review of the method and its clinical use", Bratisl Lek Listy, 105 (3), pp. 108-16.

77. Lazzeri G., Franco G., Difonzo T., Carandina A., Gramegna C. (2022), "Cognitive and Autonomic Dysfunction in Multiple System Atrophy Type P and C: A Comparative Study", Front Neurol, 13, pp. 912820.

78. Levin J., Kurz A., Arzberger T., Giese A., Höglinger G. (2016), "The Differential Diagnosis and Treatment of Atypical Parkinsonism", Deutsches Arzteblatt international, 113 (5), pp. 61-69.

79. Leys F., Fanciulli A., Ndayisaba J., Granata R., Struhal W. (2020), "Cardiovascular autonomic function testing in multiple system atrophy and Parkinson's disease: an expert-based blinded evaluation", Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 30 (3), pp. 255-263.

80. Lipp A., Sandroni P., Ahlskog J. E., Fealey R. D., Kimpinski K., et al. (2009), "Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure", Arch Neurol, 66 (6), pp. 742-50.

81. Low P. A., Tomalia V. A., Park K. J. (2013), "Autonomic function tests: some clinical applications", J Clin Neurol, 9 (1), pp. 1-8.

82. Macleod A, Counsell C (2015), "Mortality in Parkinson's disease and atypical parkinsonian disorders", Journal of Neurology, Neurosurgery & Psychiatry, 86 (11), pp. e4.

83. Magrinelli F., Picelli A. (2016), "Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and Rehabilitation", Parkinson's Disease, 2016, pp. 9832839.

84. Mantovani G., Marozzi I., Rafanelli M., Rivasi G., Volpato S. (2022), "Supine hypertension: A state of the art", Autonomic Neuroscience, 241, pp. 102988.

85. Martins Branco D., Arduino D., Esteves A. R. (2010), "Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis", Frontiers in Aging Neuroscience, 2 (17), pp. 1-10.

86. Mathias C. J. (2003), "Autonomic diseases: clinical features and laboratory evaluation", J Neurol Neurosurg Psychiatry, 74 Suppl 3, pp. iii31-41.

87. McFarland N. R. (2016), "Diagnostic Approach to Atypical Parkinsonian Syndromes", Continuum (Minneap Minn), 22 (4 Movement Disorders), pp. 1117-42.

88. McKay Jake H., Cheshire William P. (2018), "First symptoms in multiple system atrophy", Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 28 (2), pp. 215-221.

89. Mendoza-Velásquez J., Flores-Vázquez J., Barrón-Velázquez E. (2019), "Autonomic Dysfunction in α-Synucleinopathies", Frontiers in Neurology, 10 (363), pp. 1-8.

90. Merola A., Romagnolo A., Rosso M., Suri R., Berndt Z., et al. (2018), "Autonomic dysfunction in Parkinson's disease: A prospective cohort study", Mov Disord, 33 (3), pp. 391-397.

91. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease (2003), "The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations", Mov Disord, 18 (7), pp. 738- 50.

92. Munhoz Renato P., Werneck Lineu C., Teive Hélio A. G. (2010), "The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics", Clinical Neurology and Neurosurgery, 112 (5), pp. 431-435.

93. Nakajima K., Yamada M. (2016), "(123)I-Meta-iodobenzylguanidine Sympathetic Imaging: Standardization and Application to Neurological Diseases", Chonnam Med J, 52 (3), pp. 145-50.

94. Nojszewska M., Potulska-Chromik A., Jamrozik Z., Janik P., Zakrzewska-Pniewska B. (2019), "Electrophysiological and clinical assessment of dysautonomia in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP): a comparative study", Neurol Neurochir Pol, 53 (1), pp. 26-33.

95. Novak P. (2011), "Quantitative autonomic testing", J Vis Exp, (53), pp. e2502.

96. Oka H., Yoshioka M., Onouchi K., Morita M., Mochio S., et al. (2007), "Characteristics of orthostatic hypotension in Parkinson's disease", Brain, 130 (Pt 9), pp. 2425-32.

97. Oka H., Mochio S., Inoue K. (2001), "Relation between autonomic dysfunction and progression of Parkinson's disease", Rinsho Shinkeigaku, 41 (6), pp. 283-8.

98. Okubadejo N. U., Danesi M. A. (2004), "Frequency and predictors of autonomic dysfunction in Parkinson's disease: a study of African patients in Lagos, Nigeria", Niger Postgrad Med J, 11 (1), pp. 45-9.

99. Papatsoris A. G., Papapetropoulos S., Singer C., Deliveliotis C. (2008), "Urinary and erectile dysfunction in multiple system atrophy (MSA)", Neurourol Urodyn, 27 (1), pp. 22-7.

100. Park J., Yang D., Yang H., Kim H. A., Kim S., et al. (2019), "Quantitative autonomic function test in differentiation of multiple system atrophy from idiopathic Parkinson disease", Chinese Medical Journal, 132 (16), pp. 1919-1924.

101. Pavy-Le Traon A., Amarenco G., Duerr S., Kaufmann H., Lahrmann H. (2011), "The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension", Mov Disord, 26 (11), pp. 1985-92.

102. Pavy-LeTraon A., Brefel-Courbon C., Dupouy J., Ory-Magne F., Rascol O., et al. (2018), "Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson's disease", Neurophysiol Clin, 48 (2), pp. 103-110.

103. Pellecchia M. T., Stankovic I., Fanciulli A., Krismer F., Meissner W. G. (2020), "Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group", Movement Disorders Clinical Practice, 7 (7), pp. 750-762.

104. Peng L. J., Mao L. L., Bi C. F., Li L. P., Yao W., et al. (2016), "Characteristics of sympathetic skin response in patients with multiple system atrophy", Zhonghua Yi Xue Za Zhi, 96 (33), pp. 2620-2624.

105. PospíŠiL P., KoneČný L., Vank P. (2008), "Autonomic dysfunction and progression of Parkinson's disease", Scripta Medica (Brno), 81 (4), pp. 239 - 248

106. Postuma R. B., Berg D., Stern M., Poewe W., Olanow C. W., et al. (2015), "MDS clinical diagnostic criteria for Parkinson's disease", Mov Disord, 30 (12), pp. 1591-601.

107. Rada D., Seco J., Echevarria E. (2016), "Dysautonomia Differentially Influences the Effect of Affective Pain Perception on Quality of Life in Parkinson's Disease Patients", Parkinson Dis, 2016, pp. 3067426.

108. Reimann M., Schmidt C., Herting B., Prieur S., Junghanns S., et al. (2010), "Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy", J Neural Transm (Vienna), 117 (1), pp. 69-76.

109. Riley D. E., Chelimsky T. C. (2003), "Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease", J Neurol Neurosurg Psychiatry, 74 (1), pp. 56-60.

110. Sakakibara R., Uchiyama T., Yamanishi T., Kishi M. (2010), "Genitourinary dysfunction in Parkinson's disease", Mov Disord, 25 (1), pp. 2-12.

111. Schmidt C., Herting B., Prieur S., Junghanns S., Schweitzer K., et al. (2008), "Autonomic dysfunction in different subtypes of multiple system atrophy", Movement disorders : official journal of the Movement Disorder Society, 23, pp. 1766-72.

112. Shin D. H., Lee P. H., Bang O. Y., Joo I. S., Huh K. (2006), "Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes", J Clin Neurol, 2 (1), pp. 51-7.

113. Soliman H., Coffin B., Gourcerol G. (2021), "Gastroparesis in Parkinson Disease: Pathophysiology, and Clinical Management", Brain Sciences, 11 (7), pp. 831.

114. Sriranjini S. J., Ganesan M., Datta K., Pal P. K., Sathyaprabha T. N. (2011), "Effect of a single dose of standard levodopa on cardiac autonomic function in Parkinson's disease", Neurol India, 59 (5), pp. 659-63.

115. Taki J., Yoshita M., Yamada M. (2004), "Significance of123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: It can be a specific marker for Lewy body disease", Annals of Nuclear Medicine, 18 (6), pp. 453- 461.

116. Tanaka Y., Kato T., Nishida H. (2011), "Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test", J Neurol, 258 (3), pp. 421-6.

117. Tandon R., Pradhan S. (2015), "Autonomic predominant multiple system atrophy in the context of Parkinsonian and cerebellar variants", Clin Neurol Neurosurg, 130, pp. 110-3.

118. Trifonova O. P., Lokhov P. G., Archakov A. I. (2014), "Metabolic profiling of human blood", Biomed Khim, 60 (3), pp. 281-94.

119. Umemura A., Oeda T., Hayashi R., Tomita S., Kohsaka M., et al. (2013), "Diagnostic accuracy of apparent diffusion coefficient and 123I- metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease", PloS one, 8 (4), pp. e61066-e61066.

120. Unal I. (2017), "Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach", Comput Math Methods Med, 2017, pp. 3762651.

121. Utiumi Marco A. T., Felício André C., Borges Conrado R., Braatz Vera L., Rezende Sheyla A. S., et al. (2012), "Dopamine transporter imaging

in clinically unclear cases of parkinsonism and the importance of Scans Without Evidence of Dopaminergic Deficit (SWEDDs)", Arquivos de Neuro-Psiquiatria, 70, pp. 667-673.

122. Vichayanrat E., Valerio F., Koay S., De Pablo-Fernandez E., Panicker J. (2022), "Diagnosing Premotor Multiple System Atrophy: Natural History and Autonomic Testing in an Autopsy Confirmed Cohort", Neurology, pp. 10.1212.

123. Visser M., Marinus J., Stiggelbout A. M., Van Hilten J. J. (2004), "Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT", Mov Disord, 19 (11), pp. 1306-12.

124. Vo Nguyen Ngoc T., Nguyen Huu C. (2018), "Autonomic function tests in Parkinson's disease and multiple system atrophy", Parkinsonism & Related Disorders, 46, pp. e31.

125. Wang X., Han Y., Li G., Zhang B. (2019), "Association between autonomic dysfunction and olfactory dysfunction in Parkinson’s disease in southern Chinese", BMC Neurology, 19 (1), pp. 17.

126. Watanabe H., Riku Y., Hara K., Kawabata K., Nakamura T., et al. (2018), "Clinical and Imaging Features of Multiple System Atrophy: Challenges for an Early and Clinically Definitive Diagnosis", JMD, 11 (3), pp. 107-120.

127. Watanabe H., Saito Y., Terao S., Ando T., Kachi T., et al. (2002), "Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients", Brain, 125 (Pt 5), pp. 1070-83.

128. Wenning G. K., Stankovic I., Vignatelli L., Fanciulli A., Calandra- Buonaura G. (2022), "The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy", Movement Disorders, pp. 1- 18.